Acute Effects of Glucocorticoids on Serum Markers of Osteoclasts, Osteoblasts, and Osteocytes

Circulating Sclerostin Levels Are Decreased in Patients with Endogenous Hypercortisolism and Increase after Treatment

(2012) A. H. van Lierop et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Sclerostin antibody treatment enhances bone strength but does not prevent growth retardation in young mice treated with dexamethasone

(2011) M. Marenzana et al.   ARTHRITIS AND RHEUMATISM

Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW)

(2011) Adolfo Díez-Pérez et al.   BONE

Corticosterone selectively targets endo-cortical surfaces by an osteoblast-dependent mechanism

(2011) Holger Henneicke et al.   BONE

Osteoprotegerin Prevents Glucocorticoid-Induced Osteocyte Apoptosis in Mice

(2011) Robert S. Weinstein et al.   ENDOCRINOLOGY

Evidence for osteocyte regulation of bone homeostasis through RANKL expression

(2011) Tomoki Nakashima et al.   NATURE MEDICINE

Suppression of Wnt Signaling by Dkk1 Attenuates PTH-Mediated Stromal Cell Response and New Bone Formation

(2010) Jun Guo et al.   Cell Metabolism

Perspectives bone histomorphometry in glucocorticoid-induced osteoporosis

(2010) David W. Dempster   JOURNAL OF BONE AND MINERAL RESEARCH

Glucocorticoid-induced autophagy in osteocytes

(2010) Xuechun Xia et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The amazing osteocyte

(2010) Lynda F Bonewald   JOURNAL OF BONE AND MINERAL RESEARCH

Glucocorticoids, osteocytes, and skeletal fragility: The role of bone vascularity

(2009) Robert S. Weinstein   BONE

Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration

(2009) E. Voskaridou et al.   HAEMATOLOGICA

Relationships among serum receptor of nuclear factor-κB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineraldensity in postmenopausal women

(2009) Iraj Nabipour et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Bone turnover in patients with endogenous Cushing’s syndrome before and after successful treatment

(2009) Á. Szappanos et al.   OSTEOPOROSIS INTERNATIONAL

Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: A longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice

(2008) Wei Yao et al.   ARTHRITIS AND RHEUMATISM

Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease

(2008) Ann E. Kearns et al.   ENDOCRINE REVIEWS

Modulation of Dickkopf-1 Attenuates Glucocorticoid Induction of Osteoblast Apoptosis, Adipocytic Differentiation, and Bone Mass Loss

(2008) Feng-Sheng Wang et al.   ENDOCRINOLOGY

Acute changes in serum osteoprotegerin and receptor activator for nuclear factor-κB ligand levels in women with established osteoporosis treated with teriparatide

(2008) Athanasios D Anastasilakis et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma

(2008) Martin Kaiser et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Circulating Levels of Inflammatory Markers Predict Change in Bone Mineral Density and Resorption in Older Adults: A Longitudinal Study

(2008) Changhai Ding et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM